Curis reported 6.6 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Amgen 19.84 5.47 Mar/2026
AstraZeneca 25.34 4.25 Jun/2026
Bayer 3.4 8.75 Mar/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
CSL 16.16 9.59 Dec/2025
Eli Lilly 40.27 0.06 Mar/2026
Exelixis 13.91 588.4 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Incyte 14.45 0.9 Jun/2026
Merck 16.52 2.6 Mar/2026
Novartis 22.41 2.24 Jun/2026
Pfizer 9.32 5.16 Mar/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 18.96 7.12 Jun/2026
Takeda 24.4 22.12 Jun/2026
TG Therapeutics 19.64 7.65 Jun/2026